Discontinuation report FLUMIST QUADRIVALENT
| Report ID | 267589 |
| Drug Identification Number | 02426544 |
| Brand name | FLUMIST QUADRIVALENT |
| Common or Proper name | Influenza Virus Type A (H1N1), Type A (H3N2), Type B (Victoria) and Type B (Yamagata) strains |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | INFLUENZA VIRUS TYPE A INFLUENZA VIRUS TYPE B INFLUENZA VIRUS TYPE B INFLUENZA VIRUS TYPE A |
| Strength(s) | 32000000FFU 32000000FFU 32000000FFU 32000000FFU |
| Dosage form(s) | SPRAY |
| Route of administration | NASAL NASAL |
| Packaging size | 10 sprayers |
| ATC code | J07BB |
| ATC description | VIRAL VACCINES |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | 2025-09-26 |
| Actual discontinuation date | 2025-09-26 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | FLUMIST QUADRIVALENT (for the 2024/2025 season) is no longer available. |
| Company comments | FLUMIST QUADRIVALENT is being discontinued to support transition to a trivalent FLUMIST formulation for the 2025/2026 and subsequent influenza seasons. The FLUMIST trivalent formulation is aligned to the WHO recommendation that B/Yamagata lineage antigen should be excluded from influenza vaccines as it is no longer warranted. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2025-09-27 | English | Compare |
| v7 | 2025-09-26 | French | Compare |
| v6 | 2025-09-26 | English | Compare |
| v5 | 2025-09-26 | French | Compare |
| v4 | 2025-09-26 | English | Compare |
| v3 | 2025-09-22 | French | Compare |
| v2 | 2025-09-22 | English | Compare |
| v1 | 2025-09-22 | English | Compare |
Showing 1 to 8 of 8